Ventyx Biosciences (VTYX) Competitors

AEON Biopharma (NASDAQ:AEON) and Ventyx Biosciences (NASDAQ:VTYX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Do institutionals and insiders believe in AEON or VTYX?

22.8% of AEON Biopharma shares are held by institutional investors. Comparatively, 97.9% of Ventyx Biosciences shares are held by institutional investors. 20.0% of AEON Biopharma shares are held by insiders. Comparatively, 24.4% of Ventyx Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer AEON or VTYX?

Ventyx Biosciences received 25 more outperform votes than AEON Biopharma when rated by MarketBeat users. However, 100.00% of users gave AEON Biopharma an outperform vote while only 49.09% of users gave Ventyx Biosciences an outperform vote.

Company	Underperform	Outperform
AEON Biopharma	Outperform Votes 2 100.00%	Underperform Votes No Votes
Ventyx Biosciences	Outperform Votes 27 49.09%	Underperform Votes 28 50.91%

Do analysts prefer AEON or VTYX?

AEON Biopharma currently has a consensus price target of $18.00, indicating a potential upside of 175.23%. Ventyx Biosciences has a consensus price target of $21.75, indicating a potential upside of 400.00%. Given AEON Biopharma's higher probable upside, analysts plainly believe Ventyx Biosciences is more favorable than AEON Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AEON Biopharma	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ventyx Biosciences	0 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.56

Which has stronger earnings and valuation, AEON or VTYX?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AEON Biopharma	N/A	N/A	-$36.63M	N/A	N/A
Ventyx Biosciences	N/A	N/A	-$192.96M	-$3.30	-1.32

Does the media prefer AEON or VTYX?

In the previous week, Ventyx Biosciences had 5 more articles in the media than AEON Biopharma. MarketBeat recorded 11 mentions for Ventyx Biosciences and 6 mentions for AEON Biopharma. Ventyx Biosciences' average media sentiment score of 0.54 beat AEON Biopharma's score of 0.10 indicating that AEON Biopharma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AEON Biopharma	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ventyx Biosciences	0 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is AEON or VTYX more profitable?

Ventyx Biosciences' return on equity of 0.00% beat AEON Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AEON Biopharma	N/A	N/A	-46.82%
Ventyx Biosciences	N/A	-62.58%	-57.42%

Which has more risk and volatility, AEON or VTYX?

AEON Biopharma has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Ventyx Biosciences has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500.

Summary

AEON Biopharma beats Ventyx Biosciences on 7 of the 13 factors compared between the two stocks.